These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 26268080)

  • 1. EFFECT OF EICOSAPENTAENOIC ACID AND DOCOSAHEXAENOIC ACID SUPPLEMENTATIONS TO CONTROL COGNITIVE DECLINE IN DEMENTIA AND ALZHEIMER'S DISEASE: A SYSTEMATIC REVIEW.
    de Souza Fernandes DP; Canaan Rezende FA; Pereira Rocha G; De Santis Filgueiras M; Silva Moreira PR; Gonçalves Alfenas Rde C
    Nutr Hosp; 2015 Aug; 32(2):528-33. PubMed ID: 26268080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of dietary interventions in mild cognitive impairment: a systematic review.
    McGrattan AM; McEvoy CT; McGuinness B; McKinley MC; Woodside JV
    Br J Nutr; 2018 Dec; 120(12):1388-1405. PubMed ID: 30409231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain delivery of supplemental docosahexaenoic acid (DHA): A randomized placebo-controlled clinical trial.
    Arellanes IC; Choe N; Solomon V; He X; Kavin B; Martinez AE; Kono N; Buennagel DP; Hazra N; Kim G; D'Orazio LM; McCleary C; Sagare A; Zlokovic BV; Hodis HN; Mack WJ; Chui HC; Harrington MG; Braskie MN; Schneider LS; Yassine HN
    EBioMedicine; 2020 Sep; 59():102883. PubMed ID: 32690472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No Effect of Omega-3 Fatty Acid Supplementation on Cognition and Mood in Individuals with Cognitive Impairment and Probable Alzheimer's Disease: A Randomised Controlled Trial.
    Phillips MA; Childs CE; Calder PC; Rogers PJ
    Int J Mol Sci; 2015 Oct; 16(10):24600-13. PubMed ID: 26501267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omega-3 fatty acids and blood-based biomarkers in Alzheimer's disease and mild cognitive impairment: A randomized placebo-controlled trial.
    Lin PY; Cheng C; Satyanarayanan SK; Chiu LT; Chien YC; Chuu CP; Lan TH; Su KP
    Brain Behav Immun; 2022 Jan; 99():289-298. PubMed ID: 34755655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are omega-3 fatty acids options for prevention and treatment of cognitive decline and dementia?
    Cederholm T; Palmblad J
    Curr Opin Clin Nutr Metab Care; 2010 Mar; 13(2):150-5. PubMed ID: 20019606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fish intake, n-3 fatty acid body status, and risk of cognitive decline: a systematic review and a dose-response meta-analysis of observational and experimental studies.
    Kosti RI; Kasdagli MI; Kyrozis A; Orsini N; Lagiou P; Taiganidou F; Naska A
    Nutr Rev; 2022 May; 80(6):1445-1458. PubMed ID: 34605891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfer of omega-3 fatty acids across the blood-brain barrier after dietary supplementation with a docosahexaenoic acid-rich omega-3 fatty acid preparation in patients with Alzheimer's disease: the OmegAD study.
    Freund Levi Y; Vedin I; Cederholm T; Basun H; Faxén Irving G; Eriksdotter M; Hjorth E; Schultzberg M; Vessby B; Wahlund LO; Salem N; Palmblad J
    J Intern Med; 2014 Apr; 275(4):428-36. PubMed ID: 24410954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Relationship of Omega-3 Fatty Acids with Dementia and Cognitive Decline: Evidence from Prospective Cohort Studies of Supplementation, Dietary Intake, and Blood Markers.
    Wei BZ; Li L; Dong CW; Tan CC; ; Xu W
    Am J Clin Nutr; 2023 Jun; 117(6):1096-1109. PubMed ID: 37028557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of the effects of phosphatidylcholine rich in DHA and EPA on Alzheimer's disease and the possible mechanisms in CHO-APP/PS1 cells and SAMP8 mice.
    Che H; Zhou M; Zhang T; Zhang L; Ding L; Yanagita T; Xu J; Xue C; Wang Y
    Food Funct; 2018 Jan; 9(1):643-654. PubMed ID: 29292421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of fish oil on cognitive performance in older subjects: a randomized, controlled trial.
    van de Rest O; Geleijnse JM; Kok FJ; van Staveren WA; Dullemeijer C; Olderikkert MG; Beekman AT; de Groot CP
    Neurology; 2008 Aug; 71(6):430-8. PubMed ID: 18678826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline.
    Yurko-Mauro K; McCarthy D; Rom D; Nelson EB; Ryan AS; Blackwell A; Salem N; Stedman M;
    Alzheimers Dement; 2010 Nov; 6(6):456-64. PubMed ID: 20434961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validity of estimated dietary eicosapentaenoic acid and docosahexaenoic acid intakes determined by interviewer-administered food frequency questionnaire among older adults with mild-to-moderate cognitive impairment or dementia.
    Arsenault LN; Matthan N; Scott TM; Dallal G; Lichtenstein AH; Folstein MF; Rosenberg I; Tucker KL
    Am J Epidemiol; 2009 Jul; 170(1):95-103. PubMed ID: 19433614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review.
    Oscarsson J; Hurt-Camejo E
    Lipids Health Dis; 2017 Aug; 16(1):149. PubMed ID: 28797250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omega-3 fatty acids and cognitive function.
    Welty FK
    Curr Opin Lipidol; 2023 Feb; 34(1):12-21. PubMed ID: 36637075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythrocyte omega-3 fatty acids are inversely associated with incident dementia: Secondary analyses of longitudinal data from the Women's Health Initiative Memory Study (WHIMS).
    Ammann EM; Pottala JV; Robinson JG; Espeland MA; Harris WS
    Prostaglandins Leukot Essent Fatty Acids; 2017 Jun; 121():68-75. PubMed ID: 28651700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary polyunsaturated fatty acid supplementation, pre-dementia syndromes, and Alzheimer's disease.
    Panza F; Capurso C; D'Introno A; Colacicco AM; Chirico M; Capurso A; Solfrizzi V
    J Am Geriatr Soc; 2007 Mar; 55(3):469-70. PubMed ID: 17341255
    [No Abstract]   [Full Text] [Related]  

  • 18. A meta-analytic review of polyunsaturated fatty acid compositions in dementia.
    Lin PY; Chiu CC; Huang SY; Su KP
    J Clin Psychiatry; 2012 Sep; 73(9):1245-54. PubMed ID: 22938939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating CD36+ microparticles are not altered by docosahexaenoic or eicosapentaenoic acid supplementation.
    Phang M; Thorne RF; Alkhatatbeh MJ; Garg ML; Lincz LF
    Nutr Metab Cardiovasc Dis; 2016 Mar; 26(3):254-60. PubMed ID: 26803595
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.